1. Current Drug Treatment of Acute Ischemic Stroke: Challenges and Opportunities

   • Dafin F. Muresanu
   • Stefan Strilciuc
   • Adina Stan

   Current Opinion 11 September 2019 Pages: 841 - 847

   

2. Transdermal Delivery of Antipsychotics: Rationale and Current Status

   • Angela Abruzzo
   • Teresa Cerchiara
   • Federica Bigucci

   Leading Article 06 September 2019 Pages: 849 - 865

3. Recent Advances in the Drug Treatment of Dravet Syndrome

   • Elaine C. Wirrell
   • Rima Nabbout

   Review Article 23 September 2019 Pages: 867 - 881

   

4. Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases

   • Luke McAlary
   • Steven S. Plotkin
   • Neil R. Cashman

   REVIEW ARTICLE Open access 14 August 2019 Pages: 883 - 904

   

5. Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations

   • Federico Carbone
   • Atbin Djamshidian
   • Werner Poewe

   Review Article Open access 31 August 2019 Pages: 905 - 918

6. An Integrated Safety Analysis of Infants and Children with Symptomatic Spinal Muscular Atrophy (SMA) Treated with Nusinersen in Seven Clinical Trials

   • Basil T. Darras
   • Michelle A. Farrar
   • Sarah Gheuens

   Original Research Article Open access 16 August 2019 Pages: 919 - 932

   

7. Subjective Versus Objective Outcomes of Antipsychotics for the Treatment of Neuropsychiatric Symptoms Associated with Dementia

   • Eline J. Vredeveld
   • Tessa A. Hulshof
   • Hendrika J. Luijendijk

   Original Research Article Open access 31 August 2019 Pages: 933 - 942